FindMyKOL
Clinical trialNCT05870839CompletedPhase 1Interventional

Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

SponsorVaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and CompanyEnrollment121SARS-CoVSARS-CoV-2
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and immunogenicity of ascending dose levels of VXCO-100 in healthy adults.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Hope Clinic of Emory University

    Decatur, Georgia, United States

  • University of Maryland, Baltimore, Center for Vaccine Development and Global Health

    Baltimore, Maryland, United States

  • University of Rochester Medical Center - Vaccine Research Unit

    Rochester, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

VXCO-100
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 May 2023
Primary completion
10 Apr 2024
Completion
10 Apr 2024
Last update posted
10 Dec 2024
Registered enrollment
121
Registry id
NCT05870839

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.